Glycorex Transplantation AB Stock: price and insider trades · Sweden
Glycorex Transplantation AB: what insiders have been doing
This page follows insider dealings at Glycorex Transplantation AB as filed with Finansinspektionen. The past year has been quiet: not a single insider filing for Glycorex Transplantation AB. The previous disclosure was published on 23 December 2020.
Our records for Glycorex Transplantation AB go back to 2018, with no purchases and 5 sales on the open market in total.
In the same market, recent insider purchases at Dynavox Group AB and Rusta AB (publ) also feature in our signals. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Financial data
· cache
- 2,500 shares@ SEK 11.8033.1% of flowAktieFI:csv-f9a0502c33f34b64f0a0
- 5,000 shares@ SEK 12.0066.9% of flowAktieFI:csv-e581b757b899a58d67f5
- 2,800 shares@ SEK 16.7321100.0% of flowAktieFI:csv-15a88dffd4c0d753aa40
- 4,976,092 shares0TeckningsrättFI:csv-f57aebece75972a6954e
- 1,768,032 shares0TeckningsrättFI:csv-377bddd2b4c353b956af
- 31,338 shares@ SEK 2.50100.0% of flowBTA (betald tecknad aktie)FI:csv-4d1793a31c491dfb1f35
6 of 6 declarations
About Glycorex Transplantation AB
Glycorex Transplantation AB is a company focused on developing solutions for organ transplantation. It aims to improve transplant outcomes through innovative technologies.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations